REDWOOD CITY, CA, N-Power Medicine, a company reinventing the clinical trial process, announced the initial close of a Series B funding round.
N-Power Medicine, a company reinventing the clinical trial process, announced the initial close of a Series B funding round, raising its total funding to date to $72 Million. The Series B round is led by Merck Global Health Innovation Fund, with participation by a US-based healthcare focused investor.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
